Beam Therapeutics participated in investor conferences held in Boston on August 25, 2025.
2 reports, 2 independent
Updated Aug 25
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Beam Therapeutics participated in investor conferences held in Boston on August 25, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Beam Therapeutics participated in investor conferences in Boston.1 source
Analyst reduced price target on Beam stock on August 20, 2025.1 source
Keep exploring
The entities involved
-
Beam Therapeutics
American healthcare company
Nothing else this week.
-
Boston
capital and largest city of Massachusetts, United States
Related events
- Ligand Pharmaceuticals Incorporated participated in investor conferences in New York and Boston on August 26, 2026.
- Investor conferences are scheduled in Boston, and the company advises investors to follow updates via LinkedIn.
- CEO Jacek Olczak is scheduled to address investors at a conference in Boston.
Coverage
Newest first; wire copies grouped- GlobeNewswireBeam Therapeutics to Participate in Upcoming September 2025 Investor Conferences CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company dev
- Insider MonkeyJonesTrading Reduces the PT on Beam Therapeutics (BEAM), Keeps a Buy Rating Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the Best Small-Cap Growth Stocks to Buy Right Now. On August 8, JonesTrading